Results for tag:WHO
|Date:||15 November 2017|
On 16 October 2017, GHLG member Marlies Hesselman participated in an event on the new CEDAW General Recommendation on Gender and Disaster Risk Reduction in a Changing Climate. This two-part post is based on her commentary in response to the presentation of the Draft General Recommendation by CEDAW Committee member Hilary Gbedemah, and is published on the occasion of COP23 in Bonn.
|Date:||26 May 2017|
This week during the WHO’s 70th World Health Assembly, GHLG member Ellen ‘t Hoen announced the launch of the new website, ‘Medicines Law & Policy’, established with colleagues Pascale Boulet and Kaitlin Mara, all experts in intellectual property and access to medicines. ML&P provides expertise in the form of policy and legal analyses, best practice models, and other information to work toward the goal of ensuring the availability of effective, safe, and affordable medicines for all.
|Date:||16 April 2017|
In the following video, Simons joins Voices in the Field* to discuss his time working in a Sudanese refugee camp and with Romanian political prisoners, and to share one important message with colleagues and decision makers.
|Date:||01 March 2017|
At the time of writing there is a remarkable case pending in the Netherlands concerning the effects of air pollution on the health of the population. Two foundations and 57 individual plaintiffs have launched a case against the Dutch State in which they ask the court to order the State to reduce air pollution below the European maxima to the norms set in the World Health Organization (WHO) guidelines on air quality. If the case is successful, this will have significant consequences for the government as it will be ordered to protect the health of its citizens in a more effective manner by improving air quality. What are the chances of the plaintiffs succeeding in winning the case?
‘Equitable access to controlled medicine: between drug control and human rights in post-market access in low- and middle income countries’ – Conference report
|Date:||03 December 2015|
On 8 and 9 October 2015 several GHLG members participated in a symposium on ‘Equitable access to controlled medicine: between drug control and human rights in post-market access in low- and middle income countries’ (co-organized by Marie Elske Gispen, Utrecht University).
|Date:||12 November 2015|
on November 9th, 2015 the Court of First Instance in The Hague took a decision in the case concerning the close ties between the Dutch Government and the tobacco industry.
|Date:||25 September 2015|
More than twenty international law and global health experts have adopted a consensus statement on responses to non-communicable diseases (NCDs) at the end of an expert meeting in The Hague on 22 September 2015.
|Date:||02 September 2015|
Equitable access to medicines to treat non-communicable diseases (NCDs), such as cancer and diabetes, is a major public health challenge in need of a global response. In August 2015, GHLG submitted comments to the WHO’s consultation on its discussion paper Essential medicines and basic health technologies for non-communicable diseases: towards a set of actions to improve equitable access in Member States.